Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 78096 | 136.335 |
09:34 ET | 88458 | 134.985 |
09:36 ET | 28112 | 135.23 |
09:38 ET | 58185 | 133.6926 |
09:39 ET | 60431 | 134.13 |
09:41 ET | 21276 | 134.55 |
09:43 ET | 11661 | 134.74 |
09:45 ET | 57146 | 134.65 |
09:48 ET | 21720 | 134.08 |
09:50 ET | 17579 | 134.26 |
09:52 ET | 20390 | 134.03 |
09:54 ET | 19674 | 134.38 |
09:56 ET | 13507 | 134.065 |
09:57 ET | 40743 | 134.5 |
09:59 ET | 16255 | 134.35 |
10:01 ET | 19313 | 133.31 |
10:03 ET | 43527 | 132.82 |
10:06 ET | 35390 | 133.54 |
10:08 ET | 12145 | 133.3 |
10:10 ET | 7621 | 133.39 |
10:12 ET | 27091 | 132.86 |
10:14 ET | 11101 | 133.13 |
10:15 ET | 6727 | 133.105 |
10:17 ET | 5715 | 133.36 |
10:19 ET | 8097 | 133.5 |
10:21 ET | 17713 | 133.62 |
10:24 ET | 10302 | 133.08 |
10:26 ET | 27587 | 132.85 |
10:28 ET | 9979 | 132.825 |
10:30 ET | 25150 | 132.48 |
10:32 ET | 13767 | 132.68 |
10:33 ET | 24912 | 132.62 |
10:35 ET | 14504 | 132.92 |
10:37 ET | 7957 | 132.84 |
10:39 ET | 18537 | 132.56 |
10:42 ET | 13450 | 132.745 |
10:44 ET | 42597 | 131.96 |
10:46 ET | 30917 | 131.918 |
10:48 ET | 25356 | 132.015 |
10:50 ET | 29020 | 131.98 |
10:51 ET | 32195 | 132.12 |
10:53 ET | 31542 | 132.01 |
10:55 ET | 45565 | 132.28 |
10:57 ET | 7086 | 132.29 |
11:00 ET | 10463 | 132.41 |
11:02 ET | 15324 | 131.9 |
11:04 ET | 10274 | 131.955 |
11:06 ET | 19021 | 131.98 |
11:08 ET | 5959 | 132.45 |
11:09 ET | 13639 | 132.9484 |
11:11 ET | 25671 | 133 |
11:13 ET | 4988 | 133.09 |
11:15 ET | 5564 | 133.4 |
11:18 ET | 4942 | 133.13 |
11:20 ET | 7690 | 133.02 |
11:22 ET | 15192 | 133.15 |
11:24 ET | 6847 | 133.15 |
11:26 ET | 3907 | 132.96 |
11:27 ET | 5537 | 132.74 |
11:29 ET | 900 | 132.73 |
11:31 ET | 4401 | 132.945 |
11:33 ET | 8112 | 133.01 |
11:36 ET | 7195 | 132.62 |
11:38 ET | 16759 | 132.81 |
11:40 ET | 2570 | 132.7 |
11:42 ET | 21285 | 133.67 |
11:44 ET | 15821 | 133.395 |
11:45 ET | 22960 | 133.46 |
11:47 ET | 10099 | 133.42 |
11:49 ET | 8380 | 133.41 |
11:51 ET | 2120 | 133.29 |
11:54 ET | 5757 | 133.035 |
11:56 ET | 5411 | 132.78 |
11:58 ET | 4193 | 132.9001 |
12:00 ET | 11286 | 133.125 |
12:02 ET | 4153 | 133.155 |
12:03 ET | 2400 | 133.31 |
12:05 ET | 5441 | 133.125 |
12:07 ET | 1600 | 133.5211 |
12:09 ET | 8705 | 133.3572 |
12:12 ET | 5888 | 132.85 |
12:14 ET | 16591 | 132.69 |
12:16 ET | 3293 | 132.7 |
12:18 ET | 15535 | 133.2701 |
12:20 ET | 2502 | 133.55 |
12:21 ET | 13627 | 133.9225 |
12:23 ET | 12265 | 134.0501 |
12:25 ET | 10928 | 134.1902 |
12:27 ET | 21937 | 134.64 |
12:30 ET | 20577 | 134.39 |
12:32 ET | 1901 | 134.5245 |
12:34 ET | 17096 | 134.1 |
12:36 ET | 9672 | 133.98 |
12:38 ET | 4582 | 133.88 |
12:39 ET | 10884 | 133.5 |
12:41 ET | 4138 | 133.58 |
12:43 ET | 902 | 133.57 |
12:45 ET | 2136 | 133.43 |
12:48 ET | 3226 | 133.39 |
12:50 ET | 2073 | 133.66 |
12:52 ET | 5475 | 133.91 |
12:54 ET | 6664 | 133.785 |
12:56 ET | 6976 | 133.76 |
12:57 ET | 10958 | 134.41 |
12:59 ET | 5881 | 134.57 |
01:01 ET | 9468 | 134.57 |
01:03 ET | 11901 | 134.435 |
01:06 ET | 3746 | 134.43 |
01:08 ET | 2666 | 134.14 |
01:10 ET | 3209 | 134.2602 |
01:12 ET | 4282 | 134.31 |
01:14 ET | 3203 | 134.515 |
01:15 ET | 3425 | 134.4515 |
01:17 ET | 4147 | 134.14 |
01:19 ET | 1720 | 134.2 |
01:21 ET | 4189 | 134.49 |
01:24 ET | 3997 | 134.43 |
01:26 ET | 3036 | 134.31 |
01:28 ET | 5719 | 134.2 |
01:30 ET | 4487 | 134.14 |
01:32 ET | 16171 | 134.21 |
01:33 ET | 2988 | 134.495 |
01:35 ET | 3947 | 134.28 |
01:37 ET | 700 | 134.39 |
01:39 ET | 6583 | 134.48 |
01:42 ET | 500 | 134.47 |
01:44 ET | 4246 | 134.5 |
01:46 ET | 6171 | 134.645 |
01:48 ET | 4413 | 134.36 |
01:50 ET | 700 | 134.25 |
01:51 ET | 12546 | 134.02 |
01:53 ET | 3992 | 133.895 |
01:55 ET | 2414 | 134.06 |
01:57 ET | 2777 | 134.165 |
02:00 ET | 2629 | 134.09 |
02:02 ET | 2904 | 133.99 |
02:04 ET | 2300 | 133.76 |
02:06 ET | 1700 | 133.81 |
02:08 ET | 2146 | 133.92 |
02:09 ET | 2299 | 133.83 |
02:11 ET | 7089 | 133.82 |
02:13 ET | 2242 | 133.63 |
02:15 ET | 4588 | 133.79 |
02:18 ET | 2827 | 133.89 |
02:20 ET | 3295 | 133.955 |
02:22 ET | 2238 | 134.03 |
02:24 ET | 2279 | 133.82 |
02:26 ET | 1469 | 133.7275 |
02:27 ET | 3221 | 134.25 |
02:29 ET | 5500 | 134.12 |
02:31 ET | 3374 | 134.02 |
02:33 ET | 2700 | 133.98 |
02:36 ET | 2080 | 133.96 |
02:38 ET | 2938 | 134.12 |
02:40 ET | 13661 | 133.84 |
02:42 ET | 2123 | 134.11 |
02:44 ET | 3022 | 134.15 |
02:45 ET | 2427 | 133.95 |
02:47 ET | 2134 | 134.215 |
02:49 ET | 8095 | 133.93 |
02:51 ET | 2634 | 133.945 |
02:54 ET | 2561 | 133.86 |
02:56 ET | 1715 | 134 |
02:58 ET | 4427 | 133.845 |
03:00 ET | 3330 | 134.01 |
03:02 ET | 2984 | 133.92 |
03:03 ET | 8119 | 133.7074 |
03:05 ET | 2006 | 133.58 |
03:07 ET | 4017 | 133.83 |
03:09 ET | 27171 | 133.63 |
03:12 ET | 5057 | 133.85 |
03:14 ET | 6066 | 133.835 |
03:16 ET | 11981 | 133.64 |
03:18 ET | 7022 | 133.81 |
03:20 ET | 6002 | 133.85 |
03:21 ET | 8619 | 133.83 |
03:23 ET | 5383 | 133.85 |
03:25 ET | 9502 | 133.96 |
03:27 ET | 41105 | 134.25 |
03:30 ET | 29692 | 133.67 |
03:32 ET | 6243 | 133.62 |
03:34 ET | 9762 | 133.83 |
03:36 ET | 10905 | 133.935 |
03:38 ET | 7017 | 133.82 |
03:39 ET | 5831 | 133.8206 |
03:41 ET | 27746 | 133.89 |
03:43 ET | 10234 | 133.955 |
03:45 ET | 13115 | 133.88 |
03:48 ET | 8891 | 133.83 |
03:50 ET | 11655 | 133.75 |
03:52 ET | 19638 | 134.18 |
03:54 ET | 19649 | 133.745 |
03:56 ET | 53622 | 133.35 |
03:57 ET | 40650 | 133.3 |
03:59 ET | 52162 | 133.27 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 51.1B | -8.5x | --- |
ICON PLC | 26.3B | 38.7x | +4.68% |
Biogen Inc | 32.6B | 27.9x | -18.14% |
Biontech SE | 20.5B | 168.9x | --- |
Grifols SA | 6.0B | 23.2x | --- |
Incyte Corp | 13.8B | 18.7x | +39.11% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $51.1B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.67 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -8.5x |
Price/Sales (TTM) | 9.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.